| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918630 | Radiotherapy and Oncology | 2014 | 4 Pages |
Abstract
Single dose HDR-BT is feasible with acceptable levels of acute complications; tolerance may have been reached with the single 19Â Gy schedule.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Peter Hoskin, Ana Rojas, Peter Ostler, Robert Hughes, Roberto Alonzi, Gerry Lowe, Linda Bryant,